Realization of heterogeneous electrochemical CO 2 -to-fuel conversion via molecular catalysis under high-flux conditions requires the assembly of large quantities of reactantaccessible catalysts on conductive surfaces. As a proof of principle, we demonstrate that electrophoretic deposition of thin films of an appropriately chosen metal−organic framework (MOF) material is an effective method for immobilizing the needed quantity of catalyst. For electrocatalytic CO 2 reduction, we used a material that contains functionalized Fe-porphyrins as catalytically competent, redox-conductive linkers. The approach yields a high effective surface coverage of electrochemically addressable catalytic sites (∼10 15 sites/cm 2 ). The chemical products of the reduction, obtained with ∼100% Faradaic efficiency, are mixtures of CO and H 2 . These results validate the strategy of using MOF chemistry to obtain porous, electrode-immobilized, networks of molecular catalysts having competency for energyrelevant electrochemical reactions.
With the goal of improving previously reported Mn bipyridine electrocatalysts in terms of increased activity and reduced overpotential, a bulky bipyridine ligand, 6,6'-dimesityl-2,2'-bipyridine (mesbpy), was utilized to eliminate dimerization in the catalytic cycle. Synthesis, electrocatalytic properties, X-ray diffraction (XRD) studies, and infrared spectroelectrochemistry (IR-SEC) of Mn(mesbpy)(CO)3Br and [Mn(mesbpy)(CO)3(MeCN)](OTf) are reported. Unlike previously reported Mn bipyridine catalysts, these Mn complexes exhibit a single, two-electron reduction wave under nitrogen, with no evidence of dimerization. The anionic complex, [Mn(mesbpy)(CO)3](-), is formed at 300 mV more positive potential than the corresponding state is formed in typical Mn bipyridine catalysts. IR-SEC experiments and chemical reductions with KC8 provide insights into the species leading up to the anionic state, specifically that both the singly reduced and doubly reduced Mn complexes form at the same potential. When formed, the anionic complex binds CO2 with H(+), but catalytic activity does not occur until a ~400 mV more negative potential is present. The Mn complexes show high activity and Faradaic efficiency for CO2 reduction to CO with the addition of weak Brønsted acids. IR-SEC experiments under CO2/H(+) indicate that reduction of a Mn(I)-CO2H catalytic intermediate may be the cause of this unusual "over-reduction" required to initiate catalysis.
Electrocatalytic properties, X-ray crystallographic studies, and infrared spectroelectrochemistry (IR-SEC) of Mn(bpy-tBu)(CO)3Br and [Mn(bpy-tBu)(CO)3(MeCN)](OTf) are reported. Addition of Brönsted acids to CO2-saturated solutions of these Mn complexes and subsequent reduction of the complexes lead to the stable and efficient production of CO from CO2. Unlike the analogous Re catalysts, these Mn catalysts require the addition of Brönsted acids for catalytic turnover. Current densities up to 30 mA/cm(2) were observed during bulk electrolysis using 5 mM Mn(bpy-tBu)(CO)3Br, 1 M 2,2,2-trifluoroethanol, and a glassy carbon working electrode. During bulk electrolysis at -2.2 V vs SCE, a TOF of 340 s(-1) was calculated for Mn(bpy-tBu)(CO)3Br with 1.4 M trifluoroethanol, corresponding to a Faradaic efficiency of 100 ± 15% for the formation of CO from CO2, with no observable production of H2. When compared to the analogous Re catalysts, the Mn catalysts operate at a lower overpotential and exhibit similar catalytic activities. X-ray crystallography of the reduced species, [Mn(bpy-tBu)(CO)3](-), shows a five-coordinate Mn center, similar to its rhenium analogue. Three distinct species were observed in the IR-SEC of Mn(bpy-tBu)(CO)3Br. These were of the parent Mn(bpy-tBu)(CO)3Br complex, the dimer [Mn(bpy-tBu)(CO)3]2, and the [Mn(bpy-tBu)(CO)3](-) anion.
[Re(bpy)(CO)3](-) is a well-established homogeneous electrocatalyst for the reduction of CO2 to CO. Recently, substitution of the more abundant transition metal Mn for Re yielded a similarly active electrocatalyst, [Mn(bpy)(CO)3](-). Compared to the Re catalyst, this Mn catalyst operates at a lower applied reduction potential but requires the presence of a weak acid in the solution for catalytic activity. In this study, we employ quantum chemistry combined with continuum solvation and microkinetics to examine the mechanism of CO2 reduction by each catalyst. We use cyclic voltammetry experiments to determine the turnover frequencies of the Mn catalyst with phenol as the added weak acid. The computed turnover frequencies for both catalysts agree to within one order of magnitude of the experimental ones. The different operating potentials for these catalysts indicate that different reduction pathways may be favored during catalysis. We model two different pathways for both catalysts and find that, at their respective operating potentials, the Mn catalyst indeed is predicted to take a different reaction route than the Re catalyst. The Mn catalyst can access both catalytic pathways, depending on the applied potential, while the Re catalyst does not show this flexibility. Our microkinetics analysis predicts which intermediates should be observable during catalysis. These intermediates for the two catalyzed reactions have qualitatively different electronic configurations, depending on the applied potential. The observable intermediate at higher applied potentials possesses an unpaired electron and therefore should be EPR-active; however, the observable intermediate at lower applied potentials, accessible only for the Mn catalyst, is diamagnetic and therefore should be EPR-silent. The differences between both catalysts are rationalized on the basis of their electronic structure and different ligand binding affinities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.